References
-
1 Almekinders L C. Nonsteroidal anti-inflammatory drugs and corticosteroids. Bahrke MS, Yesalis CE Performance Enhancing Substances in Sport and Exercise. Champaign, IL; Human Kinetics 2002: 125-135
-
2 British Medical Association and Royal Pharmaceutical Society of Great Britain .British National Formulary. 47 edn. Oxon; Pharmaceutical Press 2004: 344-350
-
3
Campos D R, Yonamine M, de Moraes Moreau R L.
Marijuana as doping in sports.
Sports Med.
2003;
33
395-399
-
4 George A J. Peptide and glycoprotein hormones and sport. Mottram DR Drugs in Sport. 3rd ed. London; Routledge 2003: 189-204
-
5
Henzen C, Suter A, Lerch E, Urbinelli R, Schorno X H, Briner V A.
Suppression and recovery of adrenal response after short-term, high-dose glucocorticoid treatment.
The Lancet.
2000;
355
542-545
-
6 Heishman S J. Cannabis: clinical pharmacology and performance effects in humans. Bahrke MS, Yesalis CE Performance Enhancing Substances in Sport and Exercise. Champaign, IL; Human Kinetics 2002: 247-256
-
7
Kannisto S, Korppi M, Remes K, Voutilainen R.
Adrenal suppression, evaluated by a low dose adrenocorticotropin test, and growth in asthmatic children treated with inhaled steroids.
J Clinical Endocrinol Metabol.
2005;
85
652-657
-
8 Reilly T. Alcohol, anti-anxiety drugs and sport. Mottram DR Drugs in Sport. 3rd ed. London; Routledge 2003: 256-283
-
9
Sonksen P H.
Insulin, growth hormone and sport.
J Endocrinol.
2001;
170
13-25
-
10 Wallace J D, Cuneo R C. Growth hormone and sport. Kraemer WJ, Rogol AD The Endocrine System in Sports and Exercise. Oxford; Blackwell Publishing 2005: 544-577
-
11 World Anti-Doping Agency .World Anti-Doping Code. Montreal; WADA 2003
-
12 World Anti-Doping Agency .2004 adverse analytical findings reported by accredited laboratories. Overview of results. Available from: http://www.eada-ama.org/rtecontent/document/LABSTATS_2004
. November.24.2005
M. J. Petrou
National Anti Doping Committee
Nicosia
Cyprus
Email: petrou.m@cytanet.com.cy
